# Delfi Diagnostics

**Canonical:** https://apis.io/providers/delfi-diagnostics/  
**Website:** https://delfidiagnostics.com  
**APIs profiled:** 0

DELFI Diagnostics is a precision oncology company, founded in 2019 and built on research from the Johns Hopkins Kimmel Cancer Center, that combines machine learning with genome-wide analysis of cell-free DNA fragmentation patterns (an approach it calls DNA fragmentomics, or "fragmentomes") to develop accessible, blood-based cancer screening and treatment-monitoring tests. Its first commercial product, FirstLook Lung, is a laboratory-developed liquid biopsy screening test for lung cancer that runs from a simple blood draw and reports a high negative predictive value; the company also offers DELFI-TF for treatment monitoring and partners with health systems and pharmaceutical researchers. DELFI operates a CLIA laboratory and is headquartered in Palo Alto, California. This profile tracks the company in the API Evangelist network; DELFI publishes no public developer API surface.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Delfi Diagnostics Domain Security** — TLSv1.2 · DMARC

## Tags

Company, Diagnostics, Precision Oncology, Liquid Biopsy, Cancer Screening, Genomics, Machine-Learning, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/delfi-diagnostics/). Scores are computed from the provider's own public artifacts under a published rubric.